139 results on '"Jobsen, J.J."'
Search Results
2. Microcystic elongated and fragmented (MELF) pattern of invasion: Molecular features and prognostic significance in the PORTEC-1 and -2 trials
3. Limited Impact of Breast Cancer and Non-breast Malignancies on Survival in Older Patients with Early-Stage Breast Cancer: Results of a Large, Single-Centre, Population-Based Study
4. Impaired Geriatric 8 Score is Associated with Worse Survival after Radiotherapy in Older Patients with Cancer
5. OC-0508 Molecular classification of endometrial cancer is predictive of response to adjuvant radiotherapy
6. Effect of physical exercise on the hippocampus and global grey matter volume in breast cancer patients: A randomized controlled trial (PAM study).
7. Effect of physical exercise on the hippocampus and global grey matter volume in breast cancer patients: A randomized controlled trial (PAM study)
8. Factors influencing time between surgery and radiotherapy: A population based study of breast cancer patients
9. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
10. Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study)
11. Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1–pT3 bladder tumors
12. Mapping Use of Radiotherapy for Patients with Non-small Cell Lung Cancer in the Netherlands between 1997 and 2008
13. Use of Primary Radiotherapy for Rectal Cancer in the Netherlands between 1997 and 2008: A Population-based Study
14. A population-based study on the utilisation rate of primary radiotherapy for prostate cancer in 4 regions in the Netherlands, 1997–2008
15. Limited Impact of Breast Cancer and Non-breast Malignancies on Survival in Older Patients with Early-Stage Breast Cancer: Results of a Large, Single-Centre, Population-Based Study
16. The impact of margin status in breast-conserving therapy for lobular carcinoma is age related
17. Explanatory factors for variation in the use of breast conserving surgery and radiotherapy in the Netherlands, 1990–2001
18. Synchronous, bilateral breast cancer: prognostic value and incidence
19. Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
20. Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
21. The impact of age on local control in women with pT1 breast cancer treated with conservative surgery and radiation therapy
22. Family history in breast cancer is not a prognostic factor?
23. The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival
24. Breast conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population based study on 10-year overall, relative and distant metastasis-free survival in 3,071 patients
25. FIFTEEN-YEAR RADIOTHERAPY OUTCOMES OF THE RANDOMIZED PORTEC-1 TRIAL FOR ENDOMETRIAL CARCINOMA
26. Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
27. Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer
28. Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients
29. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study
30. Radiation therapy combined with hyperthermia versus cisplatin for locally advanced cervical cancer: Results of the randomized RADCHOC trial
31. Course of Quality of Life After Radiation Therapy for Painful Bone Metastases: A Detailed Analysis From the Dutch Bone Metastasis Study
32. Second Cancers in Patients Treated With Surgery and Radiation Therapy for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials
33. Quantification of LVSI Improves Its Strength as Prognostic Factor for Recurrence in Stage I Endometrial Cancer Patients Treated in the PORTEC Trials
34. Factors influencing time between breast cancer surgery and radiotherapy: a population based study
35. Explanatory factors for variation in the type of surgery in early stage breast cancer
36. No Increased Risk of Second Cancer After Radiotherapy in Patients Treated for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials
37. The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor
38. PD-0436: Long-term bowel and bladder symptoms after pelvic radiotherapy or vaginal brachytherapy in the PORTEC-2 trial
39. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
40. L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results
41. Second Cancers in Patients Treated With Surgery and Radiation Therapy for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials
42. Quantification of LVSI Improves Its Strength as Prognostic Factor for Recurrence in Stage I Endometrial Cancer Patients Treated in the PORTEC Trials
43. Trends in the use of primary radiotherapy for cancer in the Netherlands in patients with breast, prostate, rectal and lung tumors
44. Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer
45. Surgery and postoperative radiotherapy vs. surgery alone for patients with endometrial cancer: multicenter randomized trial Portec Study Group
46. Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial
47. Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients.
48. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial.
49. Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer
50. PD-0302 IMPROVED RISK ASSESSMENT OF ENDOMETRIAL CANCER PATIENTS BY ANALYSIS OF MSI, PI3K-AKT, WNT AND P53 PATHWAY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.